title: [Hyperuricemia, gout and cardiovascular diseases].
abstract: Hyperuricemia, gout as well as arterial hypertension and metabolic syndrom are highly prevalent and clinicians are frequently confronted with both conditions in the same patient. Hyperuricemia and gout are associated with cardiovascular comorbidities and a high cardiovascular risk. Despite coherent pathophysiological concepts, it remains to be determined, if this association is independent and causal. In daily clinical practice, cardiovascular risk factors should be thoroughly identified and consequently treated in all patients with hyperuricemia and gout. If preventive treatment of asymptomatic hyperuricemia with urate-lowering agents may improve cardiovascular risk and outcomes remains to be determined and is recommended only in special situations like young patients with severe hyperuricemia.
authors.affiliation: 1 Abteilung für Kardiologie, Universitätsspital Basel.|2 Klinik für Ambulante Innere Medizin und Medizinische Poliklinik, Universitätsspital Basel.
authors.forename: Karsten
authors.initials: K
authors.lastname: Murray
authors.affiliation: 1 Abteilung für Kardiologie, Universitätsspital Basel.|2 Klinik für Ambulante Innere Medizin und Medizinische Poliklinik, Universitätsspital Basel.
authors.forename: Thilo
authors.initials: T
authors.lastname: Burkard
mesh_terms: D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000453:epidemiology*; D015897:Comorbidity; D003430:Cross-Sectional Studies; D006073:Gout / Q000175:diagnosis* / Q000453:epidemiology*; D006801:Humans; D033461:Hyperuricemia / Q000175:diagnosis* / Q000453:epidemiology*; D012307:Risk Factors; D013557:Switzerland